| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
19-42 |
cell_type |
denotes |
cytotoxic T lymphocytes |
| T2 |
57-65 |
peptide |
denotes |
peptides |
| T3 |
114-127 |
protein_complex |
denotes |
Notch complex |
| T4 |
174-209 |
cell_type |
denotes |
ovarian tumor associated lymphocyte |
| T5 |
211-216 |
cell_type |
denotes |
OVTAL |
| T6 |
223-258 |
cell_type |
denotes |
breast tumor associated lymphocytes |
| T7 |
260-265 |
cell_type |
denotes |
BRTAL |
| T8 |
271-279 |
peptide |
denotes |
peptides |
| T9 |
310-361 |
protein_molecule |
denotes |
125-135 of the Aminoenhancer of split (AES) protein |
| T10 |
378-386 |
peptide |
denotes |
peptides |
| T11 |
401-411 |
peptide |
denotes |
G75:AES1/2 |
| T12 |
413-420 |
protein_domain_or_region |
denotes |
128-135 |
| T13 |
423-434 |
peptide |
denotes |
G60: AES1/2 |
| T14 |
436-443 |
protein_domain_or_region |
denotes |
127-137 |
| T15 |
449-460 |
peptide |
denotes |
G61: AES1/2 |
| T16 |
462-469 |
protein_domain_or_region |
denotes |
125-133 |
| T17 |
489-510 |
DNA_domain_or_region |
denotes |
wildtype AES sequence |
| T18 |
529-541 |
peptide |
denotes |
G76:GPLTPLPV |
| T19 |
543-559 |
protein_domain_or_region |
denotes |
AES1/2 (128-135) |
| T20 |
601-612 |
peptide |
denotes |
peptide G75 |
| T21 |
622-636 |
amino_acid_monomer |
denotes |
N-terminal Leu |
| T22 |
652-659 |
amino_acid_monomer |
denotes |
glycine |
| T23 |
707-734 |
other_name |
denotes |
mass-spectrometric analysis |
| T24 |
736-738 |
other_name |
denotes |
MS |
| T25 |
745-748 |
cell_type |
denotes |
CTL |
| T26 |
756-777 |
other_name |
denotes |
HPLC peptide fraction |
| T27 |
790-833 |
protein_molecule |
denotes |
immunoaffinity precipitated HLA-A2 molecule |
| T28 |
879-899 |
other_name |
denotes |
mass-to-charge ratio |
| T29 |
1022-1029 |
atom |
denotes |
ion 793 |
| T30 |
1054-1065 |
peptide |
denotes |
peptide G76 |
| T31 |
1094-1099 |
peptide |
denotes |
G75 ( |
| T32 |
1099-1106 |
protein_domain_or_region |
denotes |
128-135 |
| T33 |
1112-1117 |
peptide |
denotes |
G76 ( |
| T34 |
1117-1124 |
protein_domain_or_region |
denotes |
128-135 |
| T35 |
1127-1132 |
peptide |
denotes |
L128G |
| T36 |
1148-1163 |
other_name |
denotes |
CTL recognition |
| T37 |
1303-1318 |
other_name |
denotes |
CTL recognizing |
| T38 |
1325-1344 |
protein_molecule |
denotes |
epithelial tumor Ag |
| T39 |
1380-1392 |
cell_type |
denotes |
CD8+ T cells |
| T40 |
1408-1411 |
peptide |
denotes |
G75 |
| T41 |
1416-1419 |
peptide |
denotes |
G76 |
| T42 |
1489-1508 |
protein_domain_or_region |
denotes |
N-terminal residues |
| T43 |
1524-1531 |
peptide |
denotes |
peptide |
| T44 |
1570-1582 |
protein_family_or_group |
denotes |
AES proteins |
| T45 |
1646-1678 |
DNA_family_or_group |
denotes |
Enhancer of split [E(spl)] genes |
| T46 |
1769-1784 |
protein_family_or_group |
denotes |
Notch receptors |
| T47 |
1801-1813 |
peptide |
denotes |
AES peptides |
| T48 |
1845-1858 |
protein_family_or_group |
denotes |
self-antigens |
| T49 |
1897-1905 |
protein_family_or_group |
denotes |
tumor Ag |
| T50 |
1909-1927 |
other_name |
denotes |
epithelial cancers |
